Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Daniel Man-yuen Sze"'
Autor:
Rong Han, Hong Cheng Ren, Sitong Zhou, Sherman Gu, Yue-Yu Gu, Daniel Man-yuen Sze, Meng-Hua Chen
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 12, Iss 5, Pp 437-446 (2022)
Rheumatoid Arthritis (RA) remains a major global public health challenge. Disease-modifying anti-rheumatic drugs (DMARDs) are standard therapeutic drugs for RA. Conventional DMARDs (c-DMARDs) are a subgroup of approved synthetic DMARDs. The c-DMARDs
Externí odkaz:
https://doaj.org/article/cb3278992a2b429583fbcfe6f2357603
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Introduction Qigong and tai chi (QTC) have been adopted by many patients with cancer as a complementary treatment with their conventional mainstream cancer management. Findings from current systematic reviews are inconsistent. Some research indicated
Externí odkaz:
https://doaj.org/article/f5675303f6c74b4f84904f5db27bf4fb
Autor:
Gasim Dobie, Fahd A. Kuriri, Musab M.A. Omar, Fehaid Alanazi, Ali M. Gazwani, Chloe P.S. Tang, Daniel Man-yuen Sze, Sasanka M. Handunnetti, Constantine Tam, Denise E. Jackson
Publikováno v:
Blood Advances, Vol 3, Iss 24, Pp 4298-4311 (2019)
Abstract: The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has proven to be efficacious in the treatment of B-cell chronic lymphocytic leukemia (B-CLL) and related diseases. However, a major adverse side effect of ibrutinib is bleeding, includi
Externí odkaz:
https://doaj.org/article/c16341a2dbd3427fb61318c78464d555
Autor:
Grace Gar-Lee Yue, Julia Kin-Ming Lee, Ben Chung-Lap Chan, Hin-Fai Kwok, Sandy Wan-Heng Hoi, Daniel Man-Yuen Sze, Kwok-Pui Fung, Ping-Chung Leung, Clara Bik-San Lau
Publikováno v:
Chinese Medicine, Vol 13, Iss 1, Pp 1-12 (2018)
Abstract Background The incidence and mortality of cancer metastasis is high worldwide. Despite of the chemotherapeutic agents, many cancer patients still take traditional Chinese herbal prescriptions as adjuvant treatments. However, most of these he
Externí odkaz:
https://doaj.org/article/e7dc8c3caf664384a5a01ef27777342f
Autor:
Bhagwant Kaur Sekhon, Rebecca Heidi Roubin, Yiming Li, Parimala B Devi, Srinivas Nammi, Kei Fan, Daniel Man-yuen Sze
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146881 (2016)
Polysaccharopeptide (PSP), from Coriolus versicolor, has been used widely as an adjuvant to chemotherapy with demonstrated anti-tumor and broad immunomodulating effects. While PSP's mechanism of action still remains unknown, its enhanced immunomodula
Externí odkaz:
https://doaj.org/article/7c51673cc77047a6bdbd262e2d8b59db
Publikováno v:
BMJ open. 12(4)
IntroductionQigong and tai chi (QTC) have been adopted by many patients with cancer as a complementary treatment with their conventional mainstream cancer management. Findings from current systematic reviews are inconsistent. Some research indicated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a43d108b6c7f137ad6d76b5f3833e1
https://pubmed.ncbi.nlm.nih.gov/35365537
https://pubmed.ncbi.nlm.nih.gov/35365537
Autor:
Rong Han, Hong Cheng Ren, Sitong Zhou, Sherman Gu, Yue-Yu Gu, Daniel Man-yuen Sze, Meng-Hua Chen
Publikováno v:
Journal of traditional and complementary medicine. 12(5)
Rheumatoid Arthritis (RA) remains a major global public health challenge. Disease-modifying anti-rheumatic drugs (DMARDs) are standard therapeutic drugs for RA. Conventional DMARDs (c-DMARDs) are a subgroup of approved synthetic DMARDs. The c-DMARDs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f34c08804d5b435586a772c356d35d5
https://pubmed.ncbi.nlm.nih.gov/36081815
https://pubmed.ncbi.nlm.nih.gov/36081815
Autor:
Musab M A Omar, Daniel Man-Yuen Sze, Gasim Dobie, Chloe Pek Sang Tang, Ali M Gazwani, Denise E. Jackson, Constantine S. Tam, Fahd A. Kuriri, Fehaid Alanazi, Sasanka M. Handunnetti
Publikováno v:
Blood Advances. 3:4298-4311
The Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib has proven to be efficacious in the treatment of B-cell chronic lymphocytic leukemia (B-CLL) and related diseases. However, a major adverse side effect of ibrutinib is bleeding, including major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e116b3b235fbc41c70118f06486806e1
https://doi.org/10.1182/bloodadvances.2019000640
https://doi.org/10.1182/bloodadvances.2019000640
Autor:
Lan-Ting Tao, Jia-Hui Liu, Menghua Chen, Xiao-Zhong Liao, Brian H. May, Anthony Lin Zhang, Sui-Lin Mo, Daniel Man-Yuen Sze, Yue-Yu Gu
Publikováno v:
Phytomedicine. 51:214-225
Background The World Health Organization (WHO) reported that colorectal cancer (CRC) was the third most common cancer in men and the second in women, worldwide. Our previous meta-analysis found Sophora flavescens increased tumour response rate in ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf9fec46da98ee38064f977008a4b79f
https://doi.org/10.1016/j.phymed.2018.10.004
https://doi.org/10.1016/j.phymed.2018.10.004
Autor:
Menghua Chen, Daniel Man-Yuen Sze, Charlie Changli Xue, Brian H. May, Jing Cui, Anthony Lin Zhang
Publikováno v:
The Journal of Alternative and Complementary Medicine. 24:115-124
The majority of studies of integrative treatment for colorectal cancer (CRC) have been published in Chinese journals. These studies indicate potential benefits, but concerns have been raised over the quality of trials published in Chinese journals. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4565614c85d33940429896b6368a9ecb
https://doi.org/10.1089/acm.2017.0065
https://doi.org/10.1089/acm.2017.0065